Pfizer (PFE)
(Delayed Data from NYSE)
$29.55 USD
+0.06 (0.20%)
Updated Jun 5, 2024 04:00 PM ET
Pre-Market: $29.49 -0.06 (-0.20%) 9:14 AM ET
3-Hold of 5 3
B Value F Growth F Momentum D VGM
Brokerage Reports
0 items in cart
Pfizer Inc. [PFE]
Reports for Purchase
Showing records 501 - 520 ( 561 total )
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Zacks Earnings Trends: Taking Pulse of the Q2 Earnings Season, companies mentioned- INTC, IBM, MSFT, ORCL, PFE
Provider: ZACKS INVESTMENT RESEARCH
Analyst: MIAN S
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Zacks Earnings Trends: Will Earnings Growth Bottom in Q2? Companies mentioned- FDX, ORCL, PFE, ABT, MRK, DRI, WAG, AAPL
Provider: ZACKS INVESTMENT RESEARCH
Analyst: MIAN S
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Zacks Earning Trends: Q2 Earnings Expectations Remain Low- Companies mentioned: FDX,ORCL,DRI,GS,JPM,PFE,MRK
Provider: ZACKS INVESTMENT RESEARCH
Analyst: MIAN S
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Initial Overview of Planned Animal Health Spinoff
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Cost Reduction Leads to Higher Second Quarter EPS
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
1Q Results Impacted by the Lipitor Patent Expiration. Nestle to Purchase Nutrition Unit
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Specialty Pharmaceuticals Short Interest Analysis
Provider: AURIGA USA